Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Cell Therapy Catapult makes three senior appointments
Cell Therapy Catapult makes three senior appointments
Focused on the development of the UK cell therapy industry
Dow CEO wins 2013 SCI Chemical Industry Medal
Dow CEO wins 2013 SCI Chemical Industry Medal
Andrew Liveris is 6th Dow leader to receive the Medal since 1933
Sanofi president of Global Operations to retire mid-2013
Sanofi president of Global Operations to retire mid-2013
Hanspeter Spek joined the company in 1985
Amgen makes changes to board
Amgen makes changes to board
They will come into effect on 1 January 2013
Victrex team goes the distance for charity
Victrex team goes the distance for charity
Peak District hike raises funds for The Christie in Manchester
Dr Rabinder Buttar wins Scottish Asian Business Award
Dr Rabinder Buttar wins Scottish Asian Business Award
ClinTec sees 15th year of continued growth
Michael Koenig appointed to Bayer board of management
Michael Koenig appointed to Bayer board of management
Dr Richard Pott to retire, effective 1 June 2013
Sygnature Discovery appoints VP of Business Development – North America
Sygnature Discovery appoints VP of Business Development – North America
Plans to expand customer base in the US and Canada over next two years
Charlie Morris joins Almac’s clinical technologies team
Charlie Morris joins Almac’s clinical technologies team
Will oversee development of IXRS technology
Penn Pharma boosts senior management team
Penn Pharma boosts senior management team
Adds Kat Jones as director of marketing and commercial operations
Basilea appoints Ronald Scott as CEO
Basilea appoints Ronald Scott as CEO
Also expands management team with addition of Heidi McDaid
Paul O’Nion joins RSSL
Paul O’Nion joins RSSL
To head the expansion of gas chromatography and mass spectrometry services
Mymetics announces change of directors and management
Mymetics announces change of directors and management
Will explore a number of strategic opportunities for its HIV, RSV and other vaccine candidates
Novo Nordisk to create all-diabetes professional cycling team
Novo Nordisk to create all-diabetes professional cycling team
Team Novo Nordisk will promote the billion dollar drug that is never prescribed – exercise
CEO Alex Gorsky elected chairman of Johnson & Johnson
CEO Alex Gorsky elected chairman of Johnson & Johnson
Bill Weldon to step down after 41-year career at the company
Cambridge Major Laboratories hires VP of Science and Technology
Cambridge Major Laboratories hires VP of Science and Technology
Dr Prasad Raje joins the company with 15 years of industry experience
Previous
1
…
147
148
149
150
(current)
151
152
153
…
213
Next
Trending Articles
MasterControl strengthens executive leadership team with two key appointments
Wynn Clayton joins as CFO while Ian Ball is promoted to chief sales officer to support the company’s next phase of growth
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Hansa Biopharma appoints Fredrik Röök as VP Business Development
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
Ardena appoints Ariane de Ganck as Chief Scientific Officer
Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all